U. Rueffer

1.1k total citations
14 papers, 756 citations indexed

About

U. Rueffer is a scholar working on Pathology and Forensic Medicine, Neurology and Oncology. According to data from OpenAlex, U. Rueffer has authored 14 papers receiving a total of 756 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pathology and Forensic Medicine, 7 papers in Neurology and 7 papers in Oncology. Recurrent topics in U. Rueffer's work include Lymphoma Diagnosis and Treatment (13 papers), CNS Lymphoma Diagnosis and Treatment (7 papers) and Viral-associated cancers and disorders (5 papers). U. Rueffer is often cited by papers focused on Lymphoma Diagnosis and Treatment (13 papers), CNS Lymphoma Diagnosis and Treatment (7 papers) and Viral-associated cancers and disorders (5 papers). U. Rueffer collaborates with scholars based in Germany and Austria. U. Rueffer's co-authors include Andreas Josting, Andreas Engert, Volker Diehl, Jeremy Franklin, Markus Sieber, P. Koch, Hans Tesch, B. Lathan, Kai Breuer and M. Sieber and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Oncology.

In The Last Decade

U. Rueffer

14 papers receiving 728 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
U. Rueffer Germany 11 573 386 253 177 153 14 756
Henning Bredenfeld Germany 14 556 1.0× 380 1.0× 220 0.9× 222 1.3× 164 1.1× 22 833
P. Salvador United States 7 620 1.1× 386 1.0× 202 0.8× 171 1.0× 182 1.2× 7 840
Martin Soekler Germany 12 395 0.7× 273 0.7× 156 0.6× 181 1.0× 124 0.8× 23 616
Laura Clifton‐Hadley United Kingdom 15 325 0.6× 191 0.5× 147 0.6× 109 0.6× 141 0.9× 50 574
Lisa Lowry United Kingdom 9 634 1.1× 482 1.2× 229 0.9× 146 0.8× 24 0.2× 19 763
Ferial Shihadeh United States 10 329 0.6× 255 0.7× 207 0.8× 124 0.7× 61 0.4× 17 576
JR Redman United States 6 618 1.1× 396 1.0× 215 0.8× 119 0.7× 86 0.6× 8 720
Jane Myers United States 10 554 1.0× 249 0.6× 212 0.8× 252 1.4× 33 0.2× 15 614
Joseph M. Connors Canada 6 620 1.1× 387 1.0× 251 1.0× 141 0.8× 94 0.6× 7 764
John Apostolidis Greece 13 586 1.0× 473 1.2× 122 0.5× 56 0.3× 81 0.5× 34 810

Countries citing papers authored by U. Rueffer

Since Specialization
Citations

This map shows the geographic impact of U. Rueffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. Rueffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. Rueffer more than expected).

Fields of papers citing papers by U. Rueffer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U. Rueffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. Rueffer. The network helps show where U. Rueffer may publish in the future.

Co-authorship network of co-authors of U. Rueffer

This figure shows the co-authorship network connecting the top 25 collaborators of U. Rueffer. A scholar is included among the top collaborators of U. Rueffer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U. Rueffer. U. Rueffer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Rueffer, U., et al.. (2003). Spleen involvement in Hodgkin's lymphoma: assessment and risk profile. Annals of Hematology. 82(7). 390–396. 20 indexed citations
2.
3.
Rueffer, U., Kai Breuer, Andreas Josting, et al.. (2001). Male gonadal dysfunction in patients with Hodgkin’s disease prior to treatment. Annals of Oncology. 12(9). 1307–1311. 131 indexed citations
4.
Pfreundschuh, Michael, Dirk Hasenclever, Markus Loeffler, et al.. (2001). Dose escalation of cytotoxic drugs using haematopoietic growth factors: A randomized trial to determine the magnitude of increase provided by GM-CSF. Annals of Oncology. 12(4). 471–477. 10 indexed citations
5.
Rueffer, U., Andreas Josting, Jeremy Franklin, et al.. (2001). Non-Hodgkin’s Lymphoma After Primary Hodgkin’s Disease in the German Hodgkin’s Lymphoma Study Group: Incidence, Treatment, and Prognosis. Journal of Clinical Oncology. 19(7). 2026–2032. 58 indexed citations
6.
7.
Josting, Andreas, Marcel Reiser, P. Dias Wickramanayake, et al.. (2000). Brief Report Dexa-BEAM: An Effective Regimen for Cytoreduction Prior to High-Dose Chemotherapy with Autologous Stem Cell Support for Patients with Relapsed/Refractory Mantle-Cell Lymphema. Leukemia & lymphoma. 37(1-2). 185–187. 9 indexed citations
8.
Josting, Andreas, Marcel Reiser, U. Rueffer, et al.. (2000). Treatment of Primary Progressive Hodgkin’s and Aggressive Non-Hodgkin’s Lymphoma: Is There a Chance for Cure?. Journal of Clinical Oncology. 18(2). 332–332. 81 indexed citations
9.
Josting, Andreas, U. Rueffer, Jeremy Franklin, et al.. (2000). Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: a report from the German Hodgkin Lymphoma Study Group. Blood. 96(4). 1280–1286. 17 indexed citations
10.
Josting, Andreas, U. Rueffer, Jeremy Franklin, et al.. (2000). Prognostic factors and treatment outcome in primary progressive Hodgkin lymphoma: a report from the German Hodgkin Lymphoma Study Group. Blood. 96(4). 1280–1286. 161 indexed citations
11.
Greil, Richard, Bernhard Holzner, Georg Kemmler, et al.. (1999). Retrospective assessment of quality of life and treatment outcome in patients with Hodgkin's disease from 1969 to 1994. European Journal of Cancer. 35(5). 698–706. 36 indexed citations
12.
Rueffer, U., M. Sieber, Andreas Josting, et al.. (1999). Prognostic factors for subdiaphragmatic involvement in clinical stage I–II supradiaphragmatic Hodgkin’s disease: A retrospective analysis of the GHSG. Annals of Oncology. 10(11). 1343–1348. 13 indexed citations
13.
14.
Pfreundschuh, Michael, U. Rueffer, B. Lathan, et al.. (1994). Dexa-BEAM in patients with Hodgkin's disease refractory to multidrug chemotherapy regimens: a trial of the German Hodgkin's Disease Study Group.. Journal of Clinical Oncology. 12(3). 580–586. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Henning Bredenfeld Breakdown of academic impact, for papers by P. Salvador Breakdown of academic impact, for papers by Martin Soekler Breakdown of academic impact, for papers by Laura Clifton‐Hadley Breakdown of academic impact, for papers by Lisa Lowry Breakdown of academic impact, for papers by Ferial Shihadeh Breakdown of academic impact, for papers by JR Redman Breakdown of academic impact, for papers by Jane Myers Breakdown of academic impact, for papers by Joseph M. Connors Breakdown of academic impact, for papers by John Apostolidis
Rankless by CCL
2026